📰 Kea Technologies News
Kea Technologies News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Kea Technologies. Real-time updates on events, politics, business and more.
May 6, 2024
AI, pancreatic cancer and food intolerance headline wide range of Cellvizio abstracts at gastroenterology’s largest international meeting ...
May 1, 2024
Developer of Cellvizio endomicroscopy platform restructures repayment terms; opens lung cancer diagnostics center in France.
April 30, 2024
Regulatory News: Mauna Kea Technologies , inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, today announced that it has published its...
April 30, 2024
Publication of the 2023 Annual Financial Report Paris and Boston, April 30, 2024 - 5:45 p.m. CEST - Mauna Kea Technologies , inventor of...
April 29, 2024
Cellvizio utilization continues to expand globally in established and emerging clinical indications ...
April 25, 2024
Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales Full Year 2023 Sales increased +42%1 to €10.5m ...
April 25, 2024
Full Year 2023 Sales increased +42%1 to €10.5m €1.2m positive full-year operating income +47% growth in Q1 2024 in U.S. PPU volume Recent Telix strategic investment and restructured EIB...
April 2, 2024
Italy becomes the third country to launch a Cellvizio Center of Excellence following the Metrodora Institute in the U.S. and several other centers in Germany Another key milestone in a global...
February 1, 2024
01.02.2024 - Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces initiation of coverage by EuroLand Corporate. In a ...
November 13, 2023
MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea...